Estradiol down-regulates CD36 expression in human breast cancer cells

Cancer Letters

Volumn 207, Issue 1, 2004, Pages 101-107

  Uray, Ivan P ^b   Liang, Yayun ^a   Hyder, Salman M ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Angiogenesis; Breast cancer; CD36; DCC, dextran coated charcoal; Estrogen receptor; FAM, 6 carboxy fluorescein; ICI 182,780; Progesterone receptor; TAMRA, 6 carboxy tetramethyl rhodamine

Indexed keywords

CD36 ANTIGEN; ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; THROMBOSPONDIN 1;

ANTIGEN EXPRESSION; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CELL STRAIN; CELL STRAIN MCF 7; CONTROLLED STUDY; ESTROGEN ACTIVITY; HORMONAL REGULATION; HORMONE DEPENDENCE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR INTRINSIC ACTIVITY;

ANTIGENS, CD36; ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; BLOTTING, NORTHERN; BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ESTRADIOL; FEMALE; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; THROMBOSPONDIN 1; TIME FACTORS;

MINK CELL FOCUS-FORMING VIRUS;

EID: 1842525077     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2003.10.021     Document Type: Article

References (24)

1. Febbraio M., Hajjar D.P., Silverstein R.L. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J. Clin. Invest. 108:2001;785-791.
2. Jimenez B., Volpert O.V., Crawford S.E., Febbraio M., Silverstein R.L., Bouck N. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat. Med. 6:2000;41-48.
3. Rusinol A.E., Yang L., Thewke D., Panini S.R., Kramer M.F., Sinensky M.S. Isolation of a somatic cell mutant resistant to the induction of apoptosis by oxidized low density lipoprotein. J. Biol. Chem. 275:2000;7296-7303.
4. Walz D.A. Thrombospondin as a mediator of cancer cell adhesion in metastasis. Cancer Metastasis Rev. 11:1992;313-324.
5. Clezardin P., Frappart L., Clerget M., Pechoux C., Delmas P.D. Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast. Cancer Res. 53:1993;1421-1430.
6. Sparrow J.R., Ryeom S.W., Abumrad N.A., Ibrahimi A., Silverstein R.L. CD36 expression is altered in retinal pigment epithelial cells of the RCS rat. Exp. Eye Res. 64:1997;45-56.
7. Petrik J.J., Gentry P.A., Feige J.J., LaMarre J. Expression and localization of thrombospondin-1 and -2 and their cell-surface receptor, CD36, during rat follicular development and formation of the corpus luteum. Biol. Reprod. 67:2002;1522-1531.
8. Pechoux C., Clezardin P., Dante R., Serre C.M., Clerget M., Bertin N., et al. Localization of thrombospondin, CD36 and CD51 during prenatal development of the human mammary gland. Differentiation. 57:1994;133-141.
9. Hyder S.M., Chiappetta C., Stancel G.M. Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells. Int. J. Cancer. 92:2001;469-473.
10. Liang Y., Eid M.A., El Etreby F., Lewis R.W., Kumar M.V. Mifepristone-induced secretion of transforming growth factor beta1-induced apoptosis in prostate cancer cells. Int. J. Oncol. 21:2002;1259-1267.
11. Hyder S.M., Chiappetta C., Stancel G.M. Synthetic estrogen 17alpha-ethinyl estradiol induces pattern of uterine gene expression similar to endogenous estrogen 17beta-estradiol. J. Pharmacol. Exp. Ther. 290:1999;740-747.
12. Heid C.A., Stevens J., Livak K.J., Williams P.M. Real time quantitative PCR. Genome Res. 6:1996;986-994.
13. Bustin S.A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J. Mol. Endocrinol. 25:2000;169-193.
14. Albo D., Berger D.H., Wang T.N., Hu X.V., Rothman V., Tuszynski G.P. Thrombospondin-1 and transforming growth factor-beta l promote breast tumor cell invasion through up-regulation of the plasminogen/plasmin system. Surgery. 122:1997;493-499.
15. Roberts D.D. Regulation of tumor growth and metastasis by thrombospondin-1. Fed. Am. Soc. Exp. Biol. J. 10:1996;1183-1191.
16. Wang T.N., Qian X.H., Granick M.S., Solomon M.P., Rothman V.L., Berger D.H., Tuszynski G.P. Inhibition of breast cancer progression by an antibody to a thrombospondin-1 receptor. Surgery. 120:1996;449-454.
17. Wang T.N., Qian T.X., Granick M.S., Solomon M.P., Rothman V.L., Berger D.H., Tuszynski G.P. Thrombospondin-1 (TSP-1) promotes the invasive properties of human breast cancer. J. Surg. Res. 63:1996;39-43.
18. Hyder S.M., Murthy L., Stancel G.M. Progestin regulation of vascular endothelial growth factor in human breast cancer. Cancer Res. 58:1998;392-395.
19. Shibata A., Nagaya T., Imai T., Funahashi H., Nakao A., Seo H. Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells. Breast Cancer Res. Treat. 73:2002;237-243.
20. Filleur S., Volpert O.V., Degeorges A., Voland C., Reiher F., Clezardin P., et al. In vivo mechanisms by which tumors producing thrombospondin 1 by pass its inhibitory effect. Genes Develop. 15:2001;1373-1382.
21. Hyder S.M., Chiappetta S.M., Murthy L., Stancel G.M. Selective inhibition of estrogen-regulated gene expression in vivo by the pure antiestrogen ICI 182,780. Cancer Res. 57:1997;2547-2549.
22. McKenna N.J., O'Malley B.W. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell. 108:2002;465-474.
23. Lim K.B., Ng C.Y., Ong C.K., Tran E.C.S., Nguyen T.T., Chan G.M., Huynh H. Induction of apoptosis in mammary gland by a pure anti-estrogen ICI 182780. Breast Cancer Res. Treat. 68:2001;127-138.
24. Seeger H., Wallwiener D., Mueck A.O. The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells. Horm. Metab. Res. 35:2003;76-80.